The EU drug regulator could approve Covid-19 vaccines that have been adapted to target the new variant within three to four months if needed, the agency's chief said on Tuesday as she said existing shots would continue to provide protection.
Speaking to the European Parliament, European Medicines Agency (EMA) executive director Emer Cooke said it was not known if drugmakers would need to tweak their vaccines to protect against Omicron, but the agency was preparing for that possibility.
"Even if the new variant becomes more widespread, the vaccines we have will continue to provide protection," she said.
Her comments came as drugmaker Moderna's CEO set off fresh alarm bells in financial markets on Tuesday after he warned that vaccines were unlikely to be as effective against the variant first detected in southern Africa as they have been against the Delta version.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
UK's Johnson faces 'partygate' crunch
Istanbul permits first flights after snow pummels Mediterranean
US warns Russia of damaging sanctions, including on Putin
Johnson’s woes deepen with police probe into ‘partygate’
Istanbul airport shut amid snow havoc in southeast Europe
WHO chief says world at 'critical juncture' in Covid pandemic
Clashes in Brussels over Covid rules
UK accuses Kremlin of trying to install pro-Russian leader in Ukraine
Veteran French adventurer dies during solo Atlantic row